The molecular intervention analysis showed that the combinatory inhibition of oncogenic molecules e.g. PDK1, AKT, and MDM2 or the activation of P53, RB and CDH1 reduces the proliferation and increases quiescent phenotypes since the targeted drug associations blocked cancer pathways at different regions [112]. This evidence concerns the gene AKT1 and cancer.